1. China Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Xiangyu Medical Co., Ltd. Class A

Xiangyu Medical Co., Ltd. Class A

SSSE:688626
42.42
CNY
+0.94
(+2.27%)
0.58EPS
79.62P/E
7.08BMarket Cap
Oct 30Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.81
2.99
3.55
4.14
3.5
3.08
4.72
4.77
5.01
5.01
Basic EPS, GAAP
0.4
0.67
1.07
1.64
1.35
0.79
1.44
0.66
0.51
0.56
Free Cash Flow per Basic Share
0.28
0.56
1.12
0.64
0.21
-0.1
-1.59
-1.67
-0.64
- -
Dividend per Share
0.63
- -
- -
0.01
0.4
0.38
0.26
0.55
0.29
0.43
Book Value per Share
0.83
3.46
4.56
6.2
12.09
12.05
13.07
12.74
12.93
13.12
Tangible Book Value per Share
0.53
3.17
4.19
5.77
10.79
10.77
11.77
11.39
11.54
11.71
Basic Weighted Avg Shares
160
120
121
120
150
159
158
156
153
155
Sales/Revenue/Turnover
289
359
427
496
523
489
745
744
768
777
Operating Margin (%)
27.28
25.88
33.85
43.34
36.87
20.74
29.62
13.01
8.58
9.27
Depreciation Expense
7
9
10
11
11
16
18
40
56
- -
Net Income, GAAP
64
80
129
196
202
125
227
103
78
86
Effective Tax Rate (%)
16.11
14.44
12.56
12.02
10.41
7.29
6.44
4.09
- -
2.61
Profit Margin (%)
22.3
22.38
30.18
39.61
38.57
25.68
30.5
13.85
10.18
11.11
Working Capital
-18
287
404
471
1,535
1,317
822
407
535
545
LT Debt
- -
- -
- -
- -
- -
- -
8
11
88
132
Total Equity
99
415
547
743
1,946
1,940
2,107
2,055
2,080
2,111
Return on Invested Capital (%)
- -
29.04
26.08
28.58
14.5
6.41
11.13
4.55
- -
3.25
Return on Capital (%)
- -
30.68
25.93
29.34
14.92
6.55
11.14
4.67
- -
3.37
Return on Common Equity (%)
- -
31.26
26.81
30.41
15.08
6.5
11.3
4.99
3.8
4.17

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
487
523
443
LT Borrowings
81
145
126
LT Finance Leases
7
7
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
160
160
160
Market Capitalization
9,680
9,069
7,082

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,486
1,597
1,446
Cash, Cash Equivalents & STI
774
832
899
Accounts Receivable, Net
60
86
79
Inventories
304
324
358
Total Current Liabilities
951
952
902
Payables & Accruals
- -
- -
- -
ST Debt
487
523
443
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
33.77%
1.24%
Free Cash Flow
- -
233.38%
-62.59%
Net Income, GAAP
- -
-6.54%
-24.08%
Sales/Revenue/Turnover
- -
10.9%
3.26%
Total Cash Common Dividend
- -
1,461.03%
-48.09%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
169
169
169
237
744
2025
186
173
- -
231
768
2026
193
180
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
0.11
0.11
0.19
0.66
2025
0.15
0.08
- -
0.22
0.51
2026
0.16
0.09
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.53
- -
- -
0.55
2025
0.05
0.22
- -
0.01
0.29
2026
0.01
0.19
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Yong Zheng He
Full Time Employees
2,195
Sector
Health technology
Industry
Medical specialties
Address
Middle Section of Diku Avenue Anyang HN China 456300
IPO Date
Mar 31, 2021
Website
xyyl.com
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Xiangyu Medical Co., Ltd is a China-based company primarily engaged in the research, development, manufacture, and sale of medical devices and equipment. Its core product offerings include a comprehensive portfolio of medical consumables, surgical instruments, hospital furniture, diagnostic systems, and healthcare-related materials. The company serves a broad customer base across healthcare institutions, clinics, and health management organizations in China and internationally. Founded in 2004 and headquartered in Zhengzhou, Henan Province, Xiangyu Medical operates within the medical device and healthcare industry with a focus on high-quality, innovative medical products. In recent years, Xiangyu Medical has expanded its product innovation pipeline and strengthened strategic partnerships to enhance its market presence and competitiveness. The company has introduced new product lines catering to evolving clinical needs and scaled its operations through acquisitions and collaborations with medical research institutes. It has actively pursued product diversification and business expansion within China and other key markets to capture growing demand in medical consumables and advanced healthcare technology sectors. These major initiatives reflect Xiangyu Medical's ongoing commitment to sustainable growth and technological advancement in the medical device industry. Overall, Xiangyu Medical Co., Ltd stands as a leading integrated supplier of medical devices with a robust product range encompassing consumables, diagnostics, surgical instruments, and hospital equipment. Its strategic developments in product innovation and market expansion underscore its position as a significant player in China’s healthcare sector and its growing influence internationally. The company continues to leverage partnerships, research and development, and operational enhancements to support its business growth trajectory.